Chemours falls as RBC downgrades stock on persistent TiO2 weakness
Chemours Co (CC) shares dropped 2.5% premarket after RBC downgraded it to Sector Perform, citing weak TiO2 demand and reduced growth expectations. RBC cut its price target to $14 from $22 and lowered EBITDA estimates for Q3 and FY26-FY27, citing macro pressures and project delays. The analyst sees limited near-term upside and a fully valued stock at current levels.
How this was made
The 30-second read
Why it matters
The downgrade and target cut suggest near‑term earnings pressure, but cost cuts and resolved PFAS litigation may limit downside.
Market read
Chemours shares fell 2.5% pre‑market on the downgrade, indicating immediate trading relevance for short‑term investors.
What to watch
Potential cost‑reduction initiatives and de‑risked PFAS litigation could support a floor for the stock.
Background
Chemours Co (NYSE:CC) is a major producer of titanium dioxide and other specialty chemicals. The downgrade follows a broader slowdown in construction and coatings demand.
Ticker impact
RBC downgraded Chemours (CC) to Sector Perform, cut price target to $14 and lowered Q3 EBITDA to $185M, sending shares down 2.5% pre‑market.
downward pressure as investors price in weaker TiO2 demand and lower EBITDA forecasts
The downgrade reflects persistent TiO2 demand weakness and delayed TSS projects, prompting a fresh sell‑off.
Market effects
Chemours downgrade may pressure other TiO2 producers and specialty chemicals peers.
U.S. chemical sector could see modest pullback in the near term.
Limited to investors tracking specialty chemicals; no broad market effect.
Counterpoint
If TiO2 demand rebounds faster than expected, the downgrade could be premature and the stock may be oversold.
Key entities
- companyChemours Co
U.S. chemical producer, ticker CC.
- analystRBC Capital Markets
Downgraded Chemours to Sector Perform.
